Events

Stay connected – Discover our latest updates and connect with our team!

September 1, 2025

Mabqi at AI4Immuno-Oncology: Advancing Cancer Care Through AI

Mabqi participates to several events in 2025

August 28, 2025

MabQi Strengthens International Scientific Presence Through 2025

August 25, 2025

Mabqi has joined PSCC Connect

May 20, 2025

Visit Mabqi at Booth #40 during the 13th Antibody Industrial Symposium (AIS)

May 15, 2025

Mabqi to Attend 2025 BIO International Convention in Boston

May 13, 2025

Mabqi to Attend Antibody Engineering & Therapeutics Europe 2025

April 30, 2025

Mabqi to Attend BioEquity Europe 2025

April 13, 2025

Mabqi is attending Meet2Win in Bordeaux, France

Mabqi shows first-in-class and best-in-class proprietary functional antibodies with high therapeutic potential in oncology

March 25, 2025

Mabqi is attending RESI Europe Conference 2025 in Barcelona, Spain

« Previous Page1 Page2 Page3 Page4 Next »

Mabqi is a biotechnology company focused on the discovery and development of fully human antibodies. Leveraging its LiteMab© Antibody Discovery Studio, the company specializes in identifying monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), pH-sensitive antibodies, and other innovative immunotherapy formats.

Legal notice